DGX

179.04

0.20% 0.36

Handel nachbörslich: 179.04

Quest Diagnostics Inc (DGX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$178.68

Offen:

$178.87

24-Stunden-Volumen:

928.41K

Relative Volume:

0.87

Marktkapitalisierung:

$20.02B

Einnahmen:

$9.54B

Nettoeinkommen (Verlust:

$841.00M

KGV:

24.06

EPS:

7.44

Netto-Cashflow:

$1.02B

1W Leistung:

+3.49%

1M Leistung:

+6.51%

6M Leistung:

+6.12%

1J Leistung:

+18.75%

1-Tages-Spanne:

$177.59

$179.47

1-Wochen-Bereich:

$172.70

$179.47

52-Wochen-Spanne:

$146.17

$182.38

Quest Diagnostics Inc Stock (DGX) Company Profile

Firmenname

Quest Diagnostics Inc

Sektor

Healthcare (1161)

Branche

Diagnostics & Research (55)

Telefon

(973) 520-2700

Adresse

500 PLAZA DRIVE, SECAUCUS

Mitarbeiter

56,000

Twitter

@QuestDX

Nächster Verdiensttermin

2025-07-22

Neueste SEC-Einreichungen

DGX's Discussions on Twitter

Vergleichen Sie DGX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DGX Quest Diagnostics Inc	179.04	19.98B	9.54B	841.00M	1.02B	7.44
TMO Thermo Fisher Scientific Inc	484.79	180.28B	43.21B	6.58B	6.17B	17.29
DHR Danaher Corp	209.14	147.31B	24.01B	3.41B	4.86B	4.70
IDXX Idexx Laboratories Inc	663.92	52.18B	4.04B	985.66M	774.34M	12.01
A Agilent Technologies Inc	120.29	33.33B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	190.23	31.60B	15.50B	1.33B	2.16B	7.34

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-04-02	Eingeleitet	Redburn Atlantic	Buy
2025-03-04	Herabstufung	Citigroup	Buy → Neutral
2025-01-06	Hochstufung	Leerink Partners	Market Perform → Outperform
2024-12-17	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	Fortgesetzt	Jefferies	Buy
2024-10-23	Hochstufung	Robert W. Baird	Neutral → Outperform
2024-08-28	Fortgesetzt	Evercore ISI	In-line
2024-07-10	Hochstufung	Citigroup	Neutral → Buy
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2024-02-07	Hochstufung	Jefferies	Hold → Buy
2024-01-03	Eingeleitet	Barclays	Equal Weight
2023-12-12	Hochstufung	BofA Securities	Neutral → Buy
2023-06-29	Eingeleitet	Piper Sandler	Neutral
2023-05-02	Herabstufung	BofA Securities	Buy → Neutral
2023-04-03	Hochstufung	Citigroup	Sell → Neutral
2023-01-23	Eingeleitet	Evercore ISI	In-line
2022-11-17	Herabstufung	Citigroup	Neutral → Sell
2022-08-22	Fortgesetzt	Morgan Stanley	Equal-Weight
2022-04-04	Herabstufung	Citigroup	Buy → Neutral
2022-02-23	Herabstufung	UBS	Buy → Neutral
2022-02-02	Herabstufung	Jefferies	Buy → Hold
2022-01-28	Herabstufung	Deutsche Bank	Buy → Hold
2021-05-04	Hochstufung	UBS	Neutral → Buy
2021-03-12	Herabstufung	Robert W. Baird	Outperform → Neutral
2020-10-21	Hochstufung	Argus	Hold → Buy
2020-07-29	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Hochstufung	BofA Securities	Neutral → Buy
2020-06-09	Hochstufung	Wells Fargo	Underweight → Equal Weight
2020-06-02	Hochstufung	Deutsche Bank	Hold → Buy
2020-04-28	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Hochstufung	Citigroup	Neutral → Buy
2020-04-27	Hochstufung	Wolfe Research	Underperform → Peer Perform
2020-03-27	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Eingeleitet	Wells Fargo	Underweight
2020-01-07	Herabstufung	Barclays	Overweight → Equal Weight
2019-12-19	Hochstufung	BofA/Merrill	Underperform → Neutral
2019-07-15	Herabstufung	Goldman	Neutral → Sell
2019-04-02	Hochstufung	Jefferies	Hold → Buy
2019-03-18	Fortgesetzt	Credit Suisse	Neutral
2019-01-31	Herabstufung	Argus	Buy → Hold
2019-01-17	Eingeleitet	UBS	Neutral
2019-01-03	Herabstufung	BofA/Merrill	Neutral → Underperform
2018-12-03	Herabstufung	BofA/Merrill	Buy → Neutral
2018-11-30	Herabstufung	Goldman	Buy → Neutral

Alle ansehen

Quest Diagnostics Inc Aktie (DGX) Neueste Nachrichten

06:35 AM

Quest Diagnostics Declares Quarterly Cash Dividend - PR Newswire

06:35 AM

Aug 12, 2025

Published on: 2025-08-12 17:41:01 - 선데이타임즈

Aug 12, 2025

Aug 07, 2025

Major Clinical Trials Launch: New Blood Test Could Transform Post-Surgery Cancer Detection - Stock Titan

Aug 07, 2025

Aug 06, 2025

Quest Diagnostics (DGX) Insider Plans $968k Share Sale – Form 144 | SBS SEC FilingForm 6-K - Stock Titan

Aug 06, 2025

Aug 05, 2025

What to Expect From Quest Diagnostics' Q2 2025 Earnings Report - MSN

Aug 05, 2025

Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care - MarketScreener

Aug 05, 2025

Aug 03, 2025

How many analysts rate Quest Diagnostics Incorporated as a “Buy”Get exclusive market analysis for investors - Jammu Links News

Aug 03, 2025

What is Quest Diagnostics Incorporated company’s growth strategyTremendous gains - Jammu Links News

Aug 03, 2025

Quest Diagnostics Incorporated Stock Analysis and ForecastFree Predictions - Jammu Links News

Aug 03, 2025

What are the technical indicators suggesting about Quest Diagnostics IncorporatedMaximize your returns with expert insights - Jammu Links News

Aug 03, 2025

Aug 02, 2025

What catalysts could drive Quest Diagnostics Incorporated stock higher in 2025Turbocharged investment results - Jammu Links News

Aug 02, 2025

Quest Diagnostics Raises 2025 Guidance - AOL.com

Aug 02, 2025

Aug 01, 2025

Quest Diagnostics Insider Selling: A Signal of Caution or a Strategic Move Amid Strong Fundamentals? - AInvest

Aug 01, 2025

Published on: 2025-08-01 19:05:55 - metal.it

Aug 01, 2025

Is Quest Diagnostics Incorporated stock overvalued or undervaluedFinancial News Updates Backed By Experts - Jammu Links News

Aug 01, 2025

Jul 30, 2025

Earnings visualization tools for Quest Diagnostics IncorporatedVerified Signal From Chart Patterns Detected - metal.it

Jul 30, 2025

Drug Abuse Testing Market Forecast and Company Analysis - GlobeNewswire

Jul 30, 2025

Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance

Jul 30, 2025

Jul 29, 2025

Quest Diagnostics Breakthrough: New Long-Read DNA Test Revolutionizes Ataxia Movement Disorder Detection - Stock Titan

Jul 29, 2025

North America Autoimmune Disease Diagnostics Market Report - GlobeNewswire

Jul 29, 2025

North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers - Yahoo Finance

Jul 29, 2025

Jul 28, 2025

What makes Quest Diagnostics Incorporated stock price move sharplyTrade Setups With Clear Risk Limits Highlighted - metal.it

Jul 28, 2025

Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-Term - sharewise.com

Jul 28, 2025

What is the risk reward ratio of investing in Quest Diagnostics Incorporated stockInvest smarter with real-time trading alerts - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

Why is Quest Diagnostics Incorporated stock attracting strong analyst attentionMarket-beating performance - Jammu Links News

Jul 27, 2025

Published on: 2025-07-28 06:28:08 - jammulinksnews.com

Jul 27, 2025

Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Quest Diagnostics (NYSE:DGX) Stock Price - MarketBeat

Jul 27, 2025

Jul 25, 2025

What analysts say about Quest Diagnostics Incorporated stockDynamic growth stocks - PrintWeekIndia

Jul 25, 2025

How high can Quest Diagnostics Incorporated stock price go in 2025High-performance investment picks - jammulinksnews.com

Jul 25, 2025

Jul 24, 2025

Quest Diagnostics Trading Volume Drops 31.43% to $364 Million Ranking 317th Despite Stock Price Rise - AInvest

Jul 24, 2025

Options Corner: Quest Diagnostics' Post-Earnings Digestion Drama Opens A Science-Backed Opportunity - inkl

Jul 24, 2025

Quest Diagnostics’ revenue up 15.2% to USD 2.76B in Q2 2025 - Medical Buyer

Jul 24, 2025

Barclays Reaffirms Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail

Jul 24, 2025

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus

Jul 24, 2025

Jul 23, 2025

Quest Diagnostics Incorporated's (NYSE:DGX) Shares May Have Run Too Fast Too Soon - 富途牛牛

Jul 23, 2025

Quest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - ADVFN Brasil

Jul 23, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 23, 2025

Quest Diagnostics (DGX) Price Target Raised by Deutsche Bank | D - GuruFocus

Jul 23, 2025

Is Quest Diagnostics Incorporated a good long term investmentConsistently exceptional gains - Autocar Professional

Jul 23, 2025

Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MSN

Jul 23, 2025